Insider filing · GALT
Jack W Callicutt
Chief Financial Officer
profile →
Galectin Therapeutics Inc.
GALT · Healthcare · 14 filings in 24 months
ticker →
Jack W Callicutt sold $407K of Galectin Therapeutics (GALT)
Executed Nov 17 2025, disclosed Nov 19 2025, 2 days later.
Value, as filed
$407K
66,011 sh across 3 lots
Executed
Nov 17 2025
the trade date, as filed
Disclosed
Nov 19 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JCJack W Callicutt (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Galectin Therapeutics Inc. (GALT). The largest single filing was $407K of GALT (66,011 sh across 3 lots, as filed), executed Nov 17 2025.
The name
GALTHealthcare · Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic di…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jack W Callicutt in GALT
GALTSALE
Galectin Therapeutics Inc.
$100K25,732 sh × $3.90
Exec Jan 5
Filed Jan 6 · 5:30 PM ET